99 related articles for article (PubMed ID: 6850546)
1. Hodgkin's disease limited to intrathoracic sites.
Johnson DW; Hoppe RT; Cox RS; Rosenberg SA; Kaplan HS
Cancer; 1983 Jul; 52(1):8-13. PubMed ID: 6850546
[TBL] [Abstract][Full Text] [Related]
2. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
Tate DJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease stages IA and IIA. A long-term follow-up study on the gains achieved by modern therapy.
Zagars G; Rubin P
Cancer; 1985 Oct; 56(8):1905-12. PubMed ID: 4027927
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
Press OW; LeBlanc M; Lichter AS; Grogan TM; Unger JM; Wasserman TH; Gaynor ER; Peterson BA; Miller TP; Fisher RI
J Clin Oncol; 2001 Nov; 19(22):4238-44. PubMed ID: 11709567
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
6. Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients.
Leibenhaut MH; Hoppe RT; Varghese A; Rosenberg SA
J Clin Oncol; 1987 Jul; 5(7):1050-5. PubMed ID: 3598609
[TBL] [Abstract][Full Text] [Related]
7. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
9. Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease.
Horning SJ; Hoppe RT; Hancock SL; Rosenberg SA
J Clin Oncol; 1988 Dec; 6(12):1822-31. PubMed ID: 2462025
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in pathological stage IIIA Hodgkin's disease.
Hoppe RT; Rosenberg SA; Kaplan HS; Cox RS
Cancer; 1980 Sep; 46(5):1240-6. PubMed ID: 7214305
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
12. Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
Crnkovich MJ; Leopold K; Hoppe RT; Mauch PM
J Clin Oncol; 1987 Jul; 5(7):1041-9. PubMed ID: 3598608
[TBL] [Abstract][Full Text] [Related]
13. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Longo DL; Russo A; Duffey PL; Hubbard SM; Glatstein E; Hill JB; Jaffe ES; Young RC; DeVita VT
J Clin Oncol; 1991 Feb; 9(2):227-35. PubMed ID: 1988570
[TBL] [Abstract][Full Text] [Related]
15. Second malignant neoplasms in patients treated for Hodgkin's disease with radiotherapy or radiotherapy and chemotherapy.
Nelson DF; Cooper S; Weston MG; Rubin P
Cancer; 1981 Dec; 48(11):2386-93. PubMed ID: 7296488
[TBL] [Abstract][Full Text] [Related]
16. Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
Henkelmann GC; Hagemeister FB; Fuller LM
J Clin Oncol; 1988 Aug; 6(8):1293-302. PubMed ID: 3411342
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Levi JA; Wiernik PH
Cancer; 1977 May; 39(5):2158-65. PubMed ID: 404027
[TBL] [Abstract][Full Text] [Related]
18. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Cramer P; Andrieu JM
J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
